Citation Impact
Citing Papers
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Modification in the composition and metabolic properties of human low density and high density lipoproteins by different dietary fats.
1984
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
2001
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung
2005 StandoutNobel
Drug‐ResistantStreptococcus pneumoniae
1998
Short-term and Long-term Outcomes of Moxifloxacin Compared to Standard Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis
2004
Antibiotic Prescription Rates Vary Markedly Between 13 European Countries
2002
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
AIRWAY INFECTION
1998
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Collagen Deposition in a Non-Fibrotic Lung Granuloma Model after Nitric Oxide Inhibition
1998
Management of Community-Acquired Pneumonia in the Era of Pneumococcal Resistance
2000
New pathogenetic insights into the sarcoid granuloma
2000
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
2006
The Acute Respiratory Distress Syndrome
2000 Standout
Effects of 3′-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products
1995
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Predictors of Timely Antibiotic Administration for Patients Hospitalized With Community-Acquired Pneumonia From the Cluster-Randomized EDCAP Trial
2010
Antibiotics in the aquatic environment – A review – Part I
2009 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
2003
Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care
2008
Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa
2002
Nonresolving Inflammation
2010 Standout
Sarcoidosis
2013 Standout
Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children
2016 Standout
Elevated CC Chemokine Level in Bronchoalveolar Lavage Fluid Is Predictive of a Poor Outcome of Idiopathic Pulmonary Fibrosis
2009
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Guidelines for Community-Acquired Pneumonia
2004
Inflammatory Mediators, Cytokines, and Adhesion Molecules in Pulmonary Inflammation and Injury
1996
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children
1999
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection
2002
Comparison of Levofloxacin and Cefotaxime Combined With Ofloxacin for ICU Patients With Community-Acquired Pneumonia Who Do Not Require Vasopressors
2005
Brain Cell and Tissue Recovery in Rats Made Deficient in n-3 Fatty Acids by Alteration of Dietary Fat
1989 StandoutNobel
The role of bacteriolysis in the pathophysiology of inflammation, infection and post‐infectious sequelae
2002
Fluoroquinolones: Action and Resistance
2003
R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells
2006 StandoutNobel
Empirical Atypical Coverage for Inpatients With Community-Acquired Pneumonia
2005
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Effectiveness of β lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis
2005
Atherosclerosis — An Inflammatory Disease
1999 Standout
Sarcoidosis
1997 Standout
Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial
2001
Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia
2002
Comparison of Clarithromycin and Amoxicillin/Clavulanic Acid for Community-Acquired Pneumonia in???an Era of Drug-Resistant Streptococcus pneumoniae
2003
Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis.
1995
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
2003 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
The Selective CXCR2 Antagonist SB272844 Blocks Interleukin-8 and Growth-related Oncogene-α-mediated Inhibition of Spontaneous Neutrophil Apoptosis
2002
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Cancer and the chemokine network
2004 Standout
Community-acquired pneumonia
1998
Tailored Interventions to Improve Antibiotic Use for Lower Respiratory Tract Infections in Hospitals: A Cluster-Randomized, Controlled Trial
2007
Sarcoidosis
2007 Standout
Relationship Between Bacterial Flora in Sputum and Functional Impairment in Patients With Acute Exacerbations of COPD
1999
Cancer-related inflammation
2008 StandoutNature
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
2020
Keratinocyte-Derived Monocyte Chemoattractant Protein 1 (MCP-1): Analysis in a Transgenic Model Demonstrates MCP-1 Can Recruit Dendritic and Langerhans Cells to Skin
1995
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells.
1997
Guidelines for the management of adult lower respiratory tract infections
2005
Applying Sputum as a Diagnostic Tool in Pneumonia
2002
Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review
2011 Standout
Do Guidelines for Community-Acquired Pneumonia Improve the Cost-Effectiveness of Hospital Care?
2001
How antibiotics kill bacteria: from targets to networks
2010 Standout
Cytokines in human lung fibrosis
1996
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Differential Role for T Cells in the Development of Fibrotic Lesions Associated with Reovirus 1/L-Induced Bronchiolitis Obliterans Organizing Pneumonia versus Acute Respiratory Distress Syndrome
2003
Ventilator-associated Pneumonia
2002 Standout
Eosinophilic Granulocytes and Interleukin-6 Level in Bronchoalveolar Lavage Fluid Are Associated with the Development of Obliterative Bronchiolitis after Lung Transplantation
2000
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis
2007
Differential Monocyte Chemoattractant Protein-1 and Chemokine Receptor 2 Expression by Murine Lung Fibroblasts Derived from Th1- and Th2-Type Pulmonary Granuloma Models
1999
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Immunology of Tuberculosis
2001 Standout
Chemokines
1997 Standout
Antibiotics for community-acquired pneumonia in adult outpatients
2014
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Epidemiological Survey of Amoxicillin-Clavulanate Resistance and Corresponding Molecular Mechanisms in Escherichia coli Isolates in France: New Genetic Features of bla TEM Genes
2000
Myeloperoxidase and interleukin‐8 levels in chronic sinusitis
1997
The Interleukin-8 Pathway in Cancer
2008 Standout
Regulation of Monocyte Survival In Vitro by Deposited IgG: Role of Macrophage Colony-Stimulating Factor
1999
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease
2008
Three Decades of β-Lactamase Inhibitors
2010 Standout
Decreased Bioavailability of Rifampin and Other Antituberculosis Drugs in Patients with Advanced Human Immunodeficiency Virus Disease
2004
Wound Healing: A Cellular Perspective
2018 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages
2003 StandoutNobel
The Acute Respiratory Distress Syndrome
1996 Standout
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Factors Influencing the Establishment of the Neonatal Bacterial Flora
1970
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of G Gialdroni-Grassi being referenced
ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society
1998
Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: II. Two-Month, Daily Administration Study
1988
Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey
1996
Comparative Bioavailability of Isoniazid, Rifampin, and Pyrazinamide Administered in Free Combination and in a Fixed Triple Formulation Designed for Daily Use in Antituberculosis Chemotherapy: I. Single-Dose Study
1988
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
1994
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies
1996
A CONTROLLED STUDY OF THE USE OF PROPHYLACTIC ANTIMICROBIALS IN PREMATURE INFANTS
1956
Bacterial Products as Immunomodulating Agents
1985
Activity of Glucose-I-phosphate on Liver Steatosis
1958 Nature
An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society.
1996